티스토리 뷰

안녕하세요!

Baseclick 수입/공급 업체 코아사이언스 입니다.

 

자세한 상품 정보 및 관련 문의는 전화 02-858-0328 또는 info@coresciences.co.kr로 문의주시기 바랍니다.

감사합니다!

At baseclick, we are pushing the boundaries of nucleic acids therapeutics and making significant advances in cutting-edge research. Our focus on specific targeting and innovative delivery systems is paving the way for new treatments and therapies.

 

Specific targeting
One of our most recent achievements is the collaboration with the Technical University of Munich (TUM) in using Tri-mannose for targeting of macrophage in disease lung tissue (Beck et al. 2023, Nature Communication). This let to the establishing the start-up company Rnatics GmbH, bringing this approach into clinical application. In a EU wide network, funded by the European Union (Midgest, www.mitgest.eu) we started to development targeting delivery to treat mitochondrial diseases.

Enhancement of mRNA stability
In addition, we are advancing research to increase mRNA stability via incorporation of stabilizing non immunogenic nucleotides and modification of 5’ and 3’ ends of mRNA. Current dosing challenges in mRNA therapeutics are increased side effect of  lipid nanoparticles (LNPs). By focusing on cellular stabilization of mRNA, we aim to increase its therapeutic efficacy and minimize potential side effects by LNPs.

 

This is just a small part of our efforts to improve therapeutic applications and supply products for nucleic acids-based therapeutics. Our commitment is advancing nucleic acids therapeutics and personalized medicine applications.

Get your baseclick products now

 

코아사이언스 coresciences baseclick korea distributor 한국 대리점 Oligonucleotides Surface Engineering Tools PEG and Linkers Non Fluorescent Tags Fluorescent Tags Click Reagents Free Nucleosides Peptide Pools Peptide Pools Amino Acid Labeling Modified and Standard Triphosphates RNA Labeling FISH Kits & Probes Metabolic Labeling Transfection Agents Cell Stains and Imaging Reagents Cell Proliferation Kits 올리고핵산 올리고뉴클레오티드 표지